EMCDDA Home
  • EN
Search

Table INF-105. Notified cases of hepatitis C infection among injecting drug users in the EU countries, Croatia and Norway

Part (ii) Case definitions

CountryRegionNotesCommentsRef.
Reference:
Czech RepublicNATIONALACCase definition: Hepatitis C - a symptomatic case that is laboratory confirmed - detection of HCV-specific antibodies, detection of HCV nucleic acid from clinical samples. Definition and Classification of Cases ECDC TESSy. AC ; UI ; LC ; HCV-RNA. 16 ; 17 ; 21 ; 22 ; 29 ; 30 ; 33
DenmarkNATIONALACase definition: Clinical symptoms + Laboratory confirmed hepatitis C (preferably HCV-RNA, but HCV-antibidies are accepted). A ; UI ; LC ; HCV-RNA.5 ; 6 ; 9
DenmarkNATIONALCCase definition: Laboratory confirmed hepatitis C present for more than 6 months or Laboratory confirmed hepatitis C + histology. C; UI ; LC ; HCV-RNA. No-UI in 200910 ; 11 ; 12 ; 13
GermanyNATIONALACCase definition: Clinical Criteria: Any person with at least one of the following three criteria: Jaundice, Elevated serum aminotransferase levels, Abdominal pain. Laboratory Criteria: At least one of the following two criteria: Detection of hepatitis C virus nucleic acid in serum (e.g. PCR), Hepatitis C virus specific antibody response (e.g. ELISA) confirmed by a different antibody test (e.g. immunoblot). Reportable: newly laboratory confirmed hepatitis C, regardless whether acute or chronic. AC ; UI ; LC. No-UI in200932 ; 33 ; 34 ; 35 ; 36 ;37
EstoniaNATIONALA ; (1)EU case definition. Commentary to 1.2.14: Injecting Drug Users are distinguished since 2004. A ; UI ; LC; HCV-RNA.1 ; 6 ; 7
IrelandNATIONALACCase definition: Case definition: This is the first time that each case has being reported to the HPSC between 2004 and 2010, but a number of cases may have being diagnosed before 2004 and not reported to the HPSC. Each case reported has a confirmed diagnosis of hepatitis C using laboratory-based serology.A ; UI ; LC; HCV-RNA.15
ItalyNATIONALACase definition: an acute illness compatible with hepatitis and serum alanine transferase levels greater than 10 times the normal value; anti-HCV positive; IgM anti-HAV negative; IgM anti-HBc negative. A ; UI ; LC.n.a.
LatviaNATIONALACase definition: ICD-10, B17.1 A ; LC ; HCV-RNA3 ; 8 ; 9; 13; 19
LatviaNATIONALCCase definition: ICD-10, B18.2. C; UI; LC; HCV-RNA 13; 19
LithuaniaNATIONALACase definition: ICD-10, acute hepatitis C - B17.1 A ; LC ; HCV-RNA.4 ; 9 ; 15
LithuaniaNATIONALCCase definition: ICD-10, chronic hepatitis C - B18.2 C ; LC ; HCV-RNA.15
LuxembourgNATIONALACAll notified hepatitis C cases, IDU cases not available. AC ; UI ; HCV-RNA. 2007-2009 NOTIFIED_CASES_TRANSMISSION_ROUTE_KNOWN not available.No_LC No-RNA. Self-reported data.1d ; 5 ; 9 ; 10
LuxembourgNATIONALACase definition: self-reported HCV cases A; UI11
HungaryNATIONALACase definition: An illness with discrete date of onset, and (2) jaundince or elevated serum aminotransferase levels greater than 2.5 times the upper limit of normal. Serologic criteria used: + anti-HCV positive. A ; UI ; LC. In 2009/2010 No-RNA1 ; 6 ; 11 ; 14 ; 22 ; 24
MaltaNATIONALACase definition: Detection of HCV-specific antibodies. Detection of HCV nucleic acid from clinical samples. Symptomatic cases that are laboratory confirmed. A ; LC.4 ; 6
MaltaNATIONALCCase definition: Positive result for Hepatitis C without any clinical symptoms or signs C ; LC.4 ; 6
MaltaNATIONALACCase definition: No case definition. AC; UI; LC; 2010 no HCV-RNA. 8; 0
NetherlandsNATIONALACCase definition: newly diagnosed HCV-infection (acute or chronic), confirmed by lab diagnosis. AC; LC.24
NetherlandsNATIONALACase definition: Every new diagnosis of HCV infection must be notified, when suspecting a recent infection (last year). Such a suspicion of a recent infection can originate from:appearance of antibodies against HCV or increase in laboratory reactivity;having symptoms (like icterus or increased liver function disorder);exposure to relevant risks if present in recent period, including medical treatments. A ; LC; No-UI; No-RNA;24 ; 30 ; 32 ; 37; 38
PolandNATIONALACase definition: Cases with clinical picture compatible with viral hepatitis confirmed by presence of anti-HCV antibodies or genetic material, reported by clinician as acute case. A ; UI ; LC. In 2009/2010 No-RNA8 ; 15 ; 16 ; 17 ; 18
PolandNATIONALCCase definition:Cases with clinical picture compatible with viral hepatitis confirmed by presence of anti-HCV antibodies or genetic material, reported by clinician as chronic case.C; UI; LC; No-RNA 15 ; 16 ; 17 ; 18
SloveniaNATIONALACase definition: a suspected case which is laboratory confirmed (anti-HCV positive or HCV-RNA positive). A ; UI ; LC HCV-RNA. 1
SlovakiaNATIONALACase definition: Positive anti HCV, PCR A ; LC ; HCV-RNA. In 2009/2010 No-UI4 ; 5 ; 8 ; 9 ; 11
SlovakiaNATIONALCCase definition: anti HCV, PCR. C ; LC; In 2009/2010 No-UI; HCV-RNA4 ; 5 ; 8 ; 9 ; 11
FinlandNATIONALACCase definition: HCV antibody positive or HCV RNA/DNA positive Data given includes acute and chronic cases. AC ; UI ; LC6 ; 9
SwedenNATIONALACCase definition: anti-HCV positive. AC ; UI ; LC ; HCV-RNA.3 ; 11
United KingdomENGLAND AND WALESAC ; (2)Case definition: Anti-HCV positive by two EIAs, EIA and RIBA or HCV RNA positive. AC ; UI ; LC ; HCV-RNA. 41; 45 ; 63 ; 67
CroatiaNATIONALACCase definition: Individuals positive for anti-HCV. AC ; UI ; LC.n.a.
NorwayNATIONALACCase definition:Detection of anti-HCV or/and HCV-RNA. AC; UI; LC; No-RNA. 22 ; 24 ; 26
For references see Table INF-0. - Bibliographic References: part B References for Notifications Data
 

Notes:

UI - Unique Identifier

LC - Laboratory Confirmation

HCV-RNA - HCV RNA Results Collected

A - Acute cases

C - Chronic cases

AC - Acute and Chronic cases

1 - Data definition changed in 2000, see Comments

2 - Data are laboratory reports and not notifications. Not all reports include data on risk factors and the number of reports including data on these has declined since 2000. The total number of reports received each year has increased from 241 in 1992 to 8,455 in 2008.

3 - Total AC include also A and C cases

n.a. = not available

For methods and definitions see [Methods and Definitions - Drug related infectious diseases]

Definitions of notifiable HCV infections differ strongly between countries, underreporting may be large and about 80 % of acute infections are asymptomatic. Therefore numbers should not be interpreted as an estimate of real incidence and they cannot be directly compared. Trends over time and the percent IDUs among all notified cases may be more comparable between countries, although these may also be strongly affected by differences in testing patterns between countries and over time. Data for most recent year(s) may be incomplete due to reporting delay.

The figures in the table should be interpreted in conjunction with the relevant methodological comments.

Source:

Reitox national focal points.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012